Rights and permissions
About this article
Cite this article
NZ Pharmac welcomes GSK's fluticasone propionate decision. Pharmacoecon. Outcomes News 404, 11 (2003). https://doi.org/10.1007/BF03276011
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276011